Melphalan-resistant myeloma cell lines consistently express FANCF and RAD51C, which are involved in the FA/BRCA pathway for ICL repair [130], and depletion of FANCF overcomes melphalan resistance [130]. The gene discussed is FANCA; the disease is plasma cell myeloma.